Medtronic: raises annual targets

(CercleFinance.com) - On its quarterly earnings call, Medtronic said that it now targets FY 2024-25 non-GAAP EPS of $5.
42 to $5.50, compared with a previous target range of $5.40 to $5.50.

Similarly, the medical equipment supplier has raised its guidance for annual organic revenue growth to between 4.5% and 5% (from 4% to 5%), expecting to sustain growth through new product launches.

Medtronic announces Q1 non-GAAP EPS of $1.23, up 8% at constant exchange rates, on adjusted revenues of $8bn, up 2.8% as reported and up 5.3% organically.

Our underlying markets are healthy, we are demonstrating operational rigor, and new product innovation is fueling diversified growth in key healthcare technology markets, management said.


Copyright (c) 2024 CercleFinance.com. All rights reserved.